The focus of this proposal is to investigate the critical biochemical characteristics of cells that express the oncogene Ras which make them susceptible to stimuli and events that advance the process of carcinogenesis. The proposed research will investigate the novel concept that phosphatases involved in a negative feedback loop that constrains Ras-stimulated signaling are vulnerable targets during early stages in carcinogenesis. We believe that carcinogenic agents disrupt the normal mechanisms by which cells compensate for the presence of activated Ras, and thus unleash super-activated signaling cascades. The role of aberrant regulation of signaling in carcinogenesis has been primarily studied by direct stimulation of signaling pathways. The proposed studies are innovative because they focus on an important alternative mechanism by which signaling pathways can become disregulated. Specifically, the proposed studies are designed to investigate the hypothesis that at early stages in carcinogenesis the activity of Ras-stimulated signaling pathways is inhibited by the upregulation of phosphatases. The subsequent down-regulation of the phosphatases releases Ras-stimulated pathways from negative constraints, which in turn results in aberrant activation of pathways that control cell fate and function. Activation of Ras is a frequent early event in human cancers, including lung and colon cancers, which are two of the most common cancers in the U.S. Thus, there is an urgent need to understand how the presence of activated Ras oncogenes sensitizes cells to agents and events that advance carcinogenesis.
Specific Aims 1 and 2 are designed to use a variety of biochemical and molecular techniques to elucidate the mechanisms by which phosphatases that are important negative regulators of Ras-stimulated pathways are modulated in cells that express activated Ras.
Specific Aim 3 is designed to investigate the functional consequences of the disregulation of such phosphatases in cells that express activated Ras. The recognition that aberrant regulation of phosphatases is associated with various disorders, including diabetes, obesity, and cancer, has sparked an interest in phosphatases as potentially important therapeutic targets. We expect the proposed studies to provide fundamental information on how disrupting the regulation of phosphatases can contribute to the process of carcinogenesis. Such insight will help in the identification of new diagnostic tools, the development of new strategies to block the advancement of carcinogenesis, and the development of chemotherapeutic agents to treat cancers that are characterized by aberrant Ras activity. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA104609-04
Application #
7368067
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Poland, Alan P
Project Start
2005-03-01
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
4
Fiscal Year
2008
Total Cost
$223,970
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Wollack, James W; Monson, Benjamin J; Dozier, Jonathan K et al. (2014) Site-specific labeling of proteins and peptides with trans-cyclooctene containing handles capable of tetrazine ligation. Chem Biol Drug Des 84:140-7
Abate-Pella, Daniel; Zeliadt, Nicholette A; Ochocki, Joshua D et al. (2012) Photochemical modulation of Ras-mediated signal transduction using caged farnesyltransferase inhibitors: activation by one- and two-photon excitation. Chembiochem 13:1009-16
Warmka, Janel K; Solberg, Eric L; Zeliadt, Nicholette A et al. (2012) Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog. Biochem Biophys Res Commun 424:488-92
Wattenberg, Elizabeth V (2011) Modulation of protein kinase signaling cascades by palytoxin. Toxicon 57:440-8
Wollack, James W; Zeliadt, Nicholette A; Ochocki, Joshua D et al. (2010) Investigation of the sequence and length dependence for cell-penetrating prenylated peptides. Bioorg Med Chem Lett 20:161-3
Wollack, James W; Silverman, Julie M; Petzold, Christopher J et al. (2009) A minimalist substrate for enzymatic peptide and protein conjugation. Chembiochem 10:2934-43
Charlson, Aaron T; Zeliadt, Nicholette A; Wattenberg, Elizabeth V (2009) Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin. Toxicol Appl Pharmacol 241:143-53
Wollack, James W; Zeliadt, Nicholette A; Mullen, Daniel G et al. (2009) Multifunctional prenylated peptides for live cell analysis. J Am Chem Soc 131:7293-303
Zeliadt, Nicholette A; Mauro, Laura J; Wattenberg, Elizabeth V (2008) Reciprocal regulation of extracellular signal regulated kinase 1/2 and mitogen activated protein kinase phosphatase-3. Toxicol Appl Pharmacol 232:408-17
Wattenberg, Elizabeth V (2007) Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis. Am J Physiol Cell Physiol 292:C24-32